Breaking News
0

AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal

By Zacks Investment ResearchStock MarketsDec 19, 2018 09:50PM ET
www.investing.com/analysis/ab-inbev-bud-enters-booming-cannabis-realm-with-tilray-deal-200369885
AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal
By Zacks Investment Research   |  Dec 19, 2018 09:50PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Anheuser-Busch InBev SA/NV (NYSE:BUD) , also known as AB InBev, recently announced a research partnership with medicinal cannabis manufacturer — Tilray, Inc. (NASDAQ:TLRY) . This $100 million deal includes an equal investment by both the companies, enabling them to conduct joint research on non-alcoholic, cannabis-infused beverages. Notably, the alliance is confined to Canada alone, where marijuana has been recently legalized for recreational use. Commercialization of the beverages is to be decided later.

Budweiser maker, AB InBev, will participate through its subsidiary Labatt Breweries of Canada, while Tilray’s cannabis subsidiary High Park Company will make the contribution. Labatt, being one of the major breweries in the country, remains focused on the evolving consumer trends and efficiently caters to their needs. Non-alcohol beverages will include tetrahydrocannabinol (THC) and cannabidiol (CBD).

We believe, this partnership will bolster AB InBev’s position in the marijuana industry, courtesy of Tilray’s excellence in cannabis. The cannabis maker will also cherish AB InBev’s rich experience in beverages.

Markedly, AB InBev is not the first beverage company to dip its toes in the flourishing cannabis market. Change in consumer preferences has prompted the beverage industry to look for new and healthier drinks options, and cannabis-infused product has been the most lucrative solution for these companies. Leading alcohol companies like Constellation Brands, Inc. (NYSE:STZ) and Molson Coors Brewing Company (NYSE:TAP) have already entered this space. In fact, Constellation Brands has made a $5-billion investment in the marijuana biggie — Canopy Growth (NYSE:CGC) .

We note that cannabis is getting officially approved in many U.S. states for recreational purposes besides its medical usage. In fact, this increasing acceptance has been propelling several brewers to put their step forward in the pot industry. This makes us optimistic about the prospects of marijuana and the companies foraying into the space.

On the part of AB InBev, we believe this latest partnership to help the company gain exposure in the cannabis along with the THC and CBD-infused products. This, along with the company’s product innovations efforts will enable it to serve the drink enthusiasts with best product quality in this category.

Shares of AB InBev reacted little to the news yesterday. In the past three months, the stock has lost 24.6%, wider than the industry’s 21.6% decline.



Currently, AB InBev has a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>



Constellation Brands Inc (STZ): Free Stock Analysis Report

Molson Coors Brewing Company (TAP): Free Stock Analysis Report

Anheuser-Busch InBev SA/NV (BUD): Free Stock Analysis Report

Tilray, Inc. (TLRY): Free Stock Analysis Report

Canopy Growth Corporation (CGC): Free Stock Analysis Report

Original post
AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal
 
AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email